Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.rvi.0000116862.34422.a5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[HVPG minimally invasive era: exploration based on forearm venous approach].
Zhonghua Gan Zang Bing Za Zhi
January 2024
Portal Hypertension Centers, Southeast University Affiliated Zhongda Hospital, Nanjing 210009,China.
The transjugular or transfemoral approach is used as a common method for hepatic venous pressure gradient (HVPG) measurement in current practice. This study aims to confirm the safety and effectiveness of measuring HVPG via the forearm venous approach. Prospective recruitment was conducted for patients with cirrhosis who underwent HVPG measurement via the forearm venous approach at six hospitals in China and Japan from September 2020 to December 2020.
View Article and Find Full Text PDFTransjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives.
J Clin Med
October 2023
Division of Gastroenterology, Azienda Ospedaliero-Universitaria di Modena, and University of Modena and Reggio Emilia, 41121 Modena, Italy.
Article Synopsis
- Portal hypertension significantly impacts cirrhosis progression, leading to serious complications and lower survival rates; the TIPS procedure has improved due to advancements in stent technology.
- The evolution from bare metal stents (BMSs) to expanding polytetrafluoroethylene-covered stent grafts (ePTFE-SGs) has greatly increased success rates and reduced complications.
- A deeper understanding of various health factors, alongside ongoing stent technology improvements, is crucial for personalizing treatment and enhancing patient outcomes in managing portal hypertension-related issues.
The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma.
Medicina (Kaunas)
June 2023
Clinical Nutrition Unit and Internal Medicine Unit, "Madonna del Soccorso" General Hospital, Via Luciano Manara 7, 63074 San Benedetto del Tronto, Italy.
Liver cancer is very frequent, and hepatocellular carcinoma (HCC) accounts for the majority of liver cancer cases. Its growing incidence has been greatly affected by the increasing prevalence of metabolic-associated fatty liver disease (MAFLD). The latter is a new epidemic in our era.
View Article and Find Full Text PDFTransjugular Intrahepatic Portosystemic Shunt Placement: Entering the Era of Controlled Expansion.
Cardiovasc Intervent Radiol
June 2023
Department of Radiology, Section of Vascular and Interventional Radiology, University of Chicago Medicine, Chicago, IL, USA.
Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS.
Hepatol Int
August 2023
Department of Gastroenterology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
Background: The evidence in Portal pressure gradient (PPG) < 12 mmHg after transjugular intrahepatic portosystemic shunt (TIPS) for preventing rebleeding mostly comes from observations in uncovered stents era. Moreover, association between Child-Pugh classes and post-TIPS hepatic encephalopathy (HE) has indicated that tolerance of PPG reduction depends on liver function. This study aimed to investigate the optimal PPG for covered TIPS and explore the optimal threshold tailored to the Child-Pugh classes to find individualized PPG to balance rebleeding and overt HE.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!